Swedish medical technology company Integrum, a pioneer in the use of osseointegration technology, is celebrating 25 years in business. The technology was developed in the 1960s by Per-Ingvar Brånemark, a Swedish physician and research professor, for use with dental implants and was later adapted for prosthetic limbs. In 1998, Per-Ingvar’s son, CEO Rickard Brånemark, MD, founded Integrum, specializing in artificial limb technology that attached using osseointegration techniques.
The following year, Integrum’s OPRA Implant System received the CE Mark, allowing it to be distributed in Europe, and the system was soon used in the United Kingdom and Australia. In 2008, the company filed for US approval with the Food and Drug Administration and received a humanitarian device exemption in 2015.
According to Brånemark, Integrum spent the past 25 years preparing a good foundation to scale up the business over time.
“Our technology is a groundbreaking development in amputee care. I want to work with partners and investors that understand how important this technology is in improving the lives of people who lost their limbs. This is much more than a business opportunity—this is, by far, the biggest-ever change in amputee care,” Brånemark said.
